JOSEPH SPOONER: Open Payments
NPI 1548406010 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 20 payments from 11 companies in 2025. Trend: 2023 $651 · 2024 $552 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $171 |
| Novo Nordisk Inc | 2 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Amgen Inc. | 2 | $28 |
| SANOFI PASTEUR INC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
| IBSA Pharma Inc. | 1 | $20 |
Products named: NURTEC ODT, PREVNAR 20, JARDIANCE, OTEZLA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FARXIGA, Heplisav-B, GARDASIL 9.
Industry payments across TX — which companies pay providers there.
